A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

Flu, viral fever, and COVID-19 all cause fever and respiratory symptoms, but key differences in onset, symptom patterns, ...

IOC President Kirsty Coventry is ready to bring back the genetic tests that had been abandoned for over 30 years, and also ...

WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

The Wooting 80HE, with its analogue keys, Rapid Trigger, and 8,000 Hz polling rate, is a high-end mechanical gaming keyboard ...

The World Health Organization (WHO) has reached a pivotal moment in the fight against COVID-19 by prequalifying the first two rapid antigen diagnostic tests for SARS-CoV-2. This groundbreaking ...

Insights into how population, nitrogen, and root architecture drive hybrid performance through Beck’s PCR research.